Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | GFER | P55789 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14403436 | 0.92 | ALDH1A1 (0.56) | ALDH1A1SMN1; SMN2SIGMAR1TDP1TSHR | |
| SCHEMBL26207612 | 0.92 | ALDH1A1 (0.56) | ALDH1A1SMN1; SMN2SIGMAR1TDP1TSHR | |
| SCHEMBL18545126 | 0.88 | ALDH1A1 (0.43) | ALDH1A1SMN1; SMN2SIGMAR1TDP1TSHR | |
| SCHEMBL25964301 | 0.87 | ALDH1A1 (0.45) | ALDH1A1SMN1; SMN2SIGMAR1TDP1MEN1 | |
| SCHEMBL19186264 | 0.86 | ALDH1A1 (0.44) | ALDH1A1SMN1; SMN2SIGMAR1TDP1TSHR | |
| SCHEMBL21319581 | 0.84 | ALDH1A1 (0.43) | ALDH1A1SMN1; SMN2SIGMAR1TSHRMEN1 | |
| SCHEMBL12327463 | 0.84 | HSD17B10 (0.39) | ALDH1A1SMN1; SMN2TDP1KDM4EHSD17B10 | |
| SCHEMBL12327042 | 0.84 | HSD17B10 (0.39) | ALDH1A1SMN1; SMN2TDP1KDM4EHSD17B10 | |
| SCHEMBL24540412 | 0.84 | HSD17B10 (0.39) | ALDH1A1SMN1; SMN2TDP1KDM4EHSD17B10 | |
| SCHEMBL25576425 | 0.84 | HSD17B10 (0.39) | ALDH1A1SMN1; SMN2TDP1KDM4EHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230047529-A1 | METHOD FOR SYNTHESIZING ZIRCONIUM COMPLEX | JFE ENGINEERING CORPORATION (JP) | 2023-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230047529-A1 | METHOD FOR SYNTHESIZING ZIRCONIUM COMPLEX | ZRANB2, ZFP3, ZNF787 | ALDH1A1 4708/4885SMN1; SMN2 3939/4885SIGMAR1 2705/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.